ERNA vs IP · P/E 0.0, rev $582.0K vs P/E 43, $26.62B cap
Eterna Therapeutics Inc (ERNA) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
IP does not have a complete income-statement cache yet.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the ERNA and IP stock pages for the full models.
Not investment advice.